# Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA

> **NCT04104633** · NA · COMPLETED · sponsor: **Centre Hospitalier Henri Duffaut - Avignon** · enrollment: 18 (actual)

## Conditions studied

- Breast Cancer
- Colo-rectal Cancer

## Interventions

- **PROCEDURE:** Blood samples

## Key facts

- **NCT ID:** NCT04104633
- **Lead sponsor:** Centre Hospitalier Henri Duffaut - Avignon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-14
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04104633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04104633, "Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04104633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*